Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Alpha-1-antitrypsin in Bronchiectasis
NCT03383939Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jun 1996
- Primary completion
- Sep 1999
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised, single-blind trial of alpha-1-proteinase inhibitor in bronchiectasis (3 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Changes from baseline BAL levels of Alpha-1-antitrypsin at 1 month. Started Jun 1996; status: completed.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT03383939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383939.